Importance Despite advancements in cancer therapy and supportive care, childhood cancer
survivors remain at risk for chronic morbidities associated with disease and treatment, such …

BACKGROUND Survivors of childhood cancer who are treated with platinum‐based
chemotherapy and/or cranial radiation are at risk of treatment‐induced hearing loss …

PURPOSE Hearing loss is a significant late effect among childhood cancer survivors.
Recent guidelines note insufficient evidence to quantify its natural history or risk associated …

The ototoxic effects of radiotherapy have been poorly characterized. We examined adult
survivors of childhood cancer who were treated with radiotherapy, which included the head …

Background Hearing loss is a potential side effect from childhood cancer treatment. We
described the severity of hearing loss assessed by audiometry in a representative national …

Background Studies have found associations between cancer therapies and auditory
complications, but data are limited on long‐term outcomes and risks associated with multiple …

PURPOSE Sensorineural hearing loss (SNHL) is associated with intellectual and academic
declines in children treated for embryonal brain tumors. This study expands upon existing …

Hearing loss (HL) is common in childhood cancer survivors exposed to platinum
chemotherapy and/or cranial radiation and can severely impact quality of life. Early detection …

Purpose Hearing loss, a complication of cancer treatment, may reduce health-related quality
of life (HRQoL), especially in childhood cancer survivors of central nervous system (CNS) …

Background Intensified therapy with platinum‐based regimens for pediatric brain tumors has
dramatically increased the number of pediatric brain tumor survivors (PBTS) but frequently …